CME Group Reports 125% YoY Rise in Net Income in Q3 2021

US derivatives giant CME Group recently posted its financial results for the third quarter of 2021, indicating a significant increase in net income. 

More specifically, the group reported a revenue of $1.1 billion, and an operating income of $614 million in Q3 this year. This represents a decline compare to Q2 2021's $1.2 billion and $675 million, respectively.

Net income came in at $927 million, showing a jump of more than 125 percent year-over-year when compared with the same quarter of the previous year. Diluted earnings per share of the group increased to $2.58 from the Q3 of 2020’s $1.15.

On an adjusted basis, net income reached $574 million while diluted earnings per share were $1.60.

In addition, the ADV for the period totalled 17.8 million contracts, including non-U.S. ADV of 5.0 million contracts.  

Clearing and transaction fees revenue for Q3 hit $879 million. The total average rate per contract was $0.677. Market data revenue was $145 million for third-quarter 2021.

​"We saw robust volume growth in Q3 as clients continued to manage a variety of risks during these times of ongoing economic uncertainty," said CME Group Chairman and Chief Executive Officer Terry Duffy. "We remained focused on meeting the evolving needs of our clients through product innovation. Since the beginning of the year we have delivered 70 new products and solutions, including the introduction of Micro Treasury futures and new ESG-focused products in Q3. Additionally, we made significant progress executing against our long-term strategy by completing the joint venture with IHS Markit and together launching OSTTRA, our new post-trade services company."

Recently, CME Group announced that the SOFR futures contracts volume on October 18 hit a record of 396,421​, surpassing the previous record of 341,922 contracts set on June 18, 2021.